The Centers for Disease Control and Prevention yesterday released an operational planning guide for pediatric COVID-19 vaccination and preliminary information on the pediatric Pfizer COVID-19 vaccine. The Food and Drug Administration is considering whether to authorize emergency use of the Pfizer vaccine for children aged 5-11, with a decision expected in the coming weeks. The new planning documents expand on an initial CDC document released this week on packaging changes and storage requirements for the Pfizer pediatric COVID-19 vaccine for children ages 5-11. The new planning guide includes additional information about the rollout of the pediatric vaccine; projected launch plan considerations for jurisdictions; and a readiness checklist for supply and ordering, provider network adequacy, information technology systems for reporting and monitoring, and communications.

Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…